4.5 Article

Metformin protects against ethanol-induced liver triglyceride accumulation by the LKB1/AMPK/ACC pathway

Journal

MOLECULAR BIOLOGY REPORTS
Volume 49, Issue 8, Pages 7837-7848

Publisher

SPRINGER
DOI: 10.1007/s11033-022-07610-y

Keywords

ALD; Metformin; AMPK; LKB1; ACC

Funding

  1. National Natural Science Foundation of China [81900535]
  2. Natural Science Foundation of Fujian Province [2021J05038]

Ask authors/readers for more resources

This study found that metformin can protect against lipid formation in ALD by activating the LKB1/AMPK/ACC axis. This research is important for understanding the lipid metabolism mechanisms in ALD and developing therapeutic strategies for ALD.
Background Hepatic lipid accumulation is one of the main pathological features of alcoholic liver disease (ALD). Metformin serves as an AMPK activator and has been shown to have lipids lowering effects in non-alcoholic fatty liver disease (NAFLD), but its role in ALD remains unclear. The purpose of this study was to explore the potential mechanism of metformin regulating lipid metabolism in ALD. Methods and results In vitro and in vivo ALD models were established using AML12 cells and C57BL/6 mice, respectively. To determine the effect of metformin on ALD in vitro, the concentration of cellular triglyceride was examined by Nile red staining and a biochemical kit. To further reveal the role of metformin on ALD in vivo, liver tissues were examined by HE and oil red O staining, and the levels of ALT and AST in serum were determined via an automatic biochemical analyzer. The expression of mRNA and proteins were measured using qRT-PCR and Western blot, respectively. The role of the LKB1/AMPK/ACC axis on metformin regulating ethanol-induced lipid accumulation was evaluated by siRNA and AAV-shRNA interference. The results showed metformin reduced the ethanol-induced lipid accumulation in AML12 cells through activating AMPK, inhibiting ACC, reducing SREBP1c, and increasing PPAR alpha. In addition, compared with control mice, metformin treatment inhibited ethanol-induced liver triglyceride accumulation and the increase of ALT and AST in serum. Interference with LKB1 attenuated the effect of metformin on ethanol-induced lipid accumulation both in vitro and in vivo. Conclusion Metformin protects against lipid formation in ALD by activating the LKB1/AMPK/ACC axis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available